Align Technology (ALGN) logo

Align Technology (ALGN) stock

Clear teeth aligners , market cap $11B

After-hours
$151.58
0.00%

Close $151.58 -1.65%

As of 7:55 PM ET after-hours, delayed 15+ min · Live for Pro members

Quality Score
4
Below Average
In its industry
#45of 85

ALGN's Quality Score rose 1 point on Tue, Nov 3, to 4.

See ALGN's 14 chart checksSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why is ALGN down?

Down 77% over five years while the S&P 500 rose 74%; up 11% in the past year.

“We expect Systems & Services revenue to be down sequentially, consistent with typical Q1 seasonality.”

Align Technology's Feb 4 release said

Sources: Price history, Nov 2, 2026; Company release, Feb 4, 2026

1 more reason, free with an account →2 more reasons why ALGN lags the market, from its filings, with the other side, the company's words, and the timeline, for Pro members.

Key facts on ALGN

Key facts on ALGN
Since its Nov 2021 highDown 78% profit $772M → $413.6M a year
Latest filing8-K, Oct 28 Reported a change of officers or directors
1 more reason behind ALGN's 4, free with an account →1 more reason behind ALGN's 4, for Pro members.

ALGN in the news

Big story

Wed Oct 28: Leadership

Align Technology filed an 8-K reporting a change of CEO

ALGN closed +0.1% the next session (Oct 29) on 2.2x normal volume.

From the company's SEC filing

ALGN catalysts

Coming up

After its last 4 reports it closed +1.0% on average, higher 2 of 4 times.

34 past catalysts since 2018, with sizes and sources, for Pro members.Get in free →

Why ALGN scores 4

Below Averagefor quality, not price, 4 of 14 chart checks firingWhat the Quality Score means

  • +4Chart checks 4 of 14 firing right now, one point each
  • −2Long-term trend below a falling 200-⁠day average, down over two years
  • Size adds
  • Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.

No effect today: Run-up, Growth, Dilution, Volatility, Cash flow, Persistence, and News.

What every line is worth, and the reason behind it, on ALGN and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 7:55 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Alert me when ALGN's Quality Score turns up

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Here is what Pro members see.

  • The same page for Pro members, on AMD

    Its Quality Score and rank, the line that drives it, and the live price.

  • The full chart

    A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.

  • Every line of the score

    Price action, the company, and signals, each with its points, on ALGN and every other stock.

  • CEOs buying their own stock

    Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.

  • Congress trades

    A member's trades, newest first, each with its amount. Sort and filter the whole list.

  • 14 chart checks, read for you

    The ones firing on the stock, each in plain words, its rule a tap away.

  • Earnings, week by week

    Who reports each day, and how each stock took its last four reports.

  • FDA dates, counted down

    Each date in the company's words, its cash against the date, and an optional alert before it.

  • The market map

    Every stock a box, colored by its Quality Score.

  • Themes, ranked live

    Each theme's stocks ranked by Quality Score, live. Here, AI chips.

  • The top 10, every day

    The ten highest Quality Scores at each close, kept day by day, week by week.

  • Optional alerts, your way

    Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.

  • Your watchlist, scored

    Your stocks by Quality Score, today's move, or name.

  • On your phone and your laptop

    The same account and watchlist on both, each laid out for its screen.

  • Prices refresh every 2.5 seconds during market hours.
  • Optional alerts by push, email, or the bell.
  • Add it to your Home Screen and it opens like an app.

ALGN has 4 of 14 chart checks firing

Volume1 of 3 shown
Tight range1 of 3 shown
Buying1 of 3 shown
The other 10 checks on ALGN, and all 14 on every stock.Get in free →

ALGN RSI today: 52.1, above its 50-day, below its 200-day

Not scored

Not in the Quality Score: over 20 years of tests, 2006 to 2026, they added no edge.

  • RSI 1452.1

    Above 50, below 70.

  • MACD (12, 26, 9)Above signal

    Crossed above its signal line 18 sessions ago.

  • The price is 1.0% above it.

  • The price is 10.1% below it.

  • 50/200 crossDeath cross

    The 50-day crossed below the 200-day on Sep 9.

  • ADX 1421.0

    Under 25, with +DI above -DI.

  • Support$138.05

    Swing low from Oct 8, 8.9% below the price.

  • Resistance$154.10

    Swing high from Sep 22, 1.7% above the price.

  • From Apr 21, 32.2% above the price.

  • From Nov 18, 2025, 14.1% below the price.

  • Chart patternFalling channel

    Lines over the Jul 30 and Aug 14 highs and under the Jul 31 and Oct 8 lows.

  • The bands run from $138.93 to $158.74.

  • Volume0.6x

    Against its 20-day average, for the time of day.

The deep dive on ALGN

11 more findings on ALGN, each with its source, for Pro membersGet in free →

How ALGN ranks in Medical Devices

ALGN is #45 of 85 by Quality Score.

How ALGN ranks in Medical Devices
45Align Technology (ALGN) logoALGNAlign Technology4

More in Medical Devices

When does ALGN report earnings, and what happens after?

Expected to report Wed Feb 3, after the close (in 92 days). Expected.

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What ALGN reported on Oct 28, 2026

The quarter

Sales of $1.0B, 2% more than a year ago; a profit of $1.90 a share, from $0.78.

“From a profitability perspective, non-GAAP gross margin was 70.4%, modestly below our expectation, reflecting higher fuel-related transportation costs, lower Clear Aligner ASPs and geographic and product mix.”

The quarter that ended Sep 30, from the company's press release

The press releaseThe filing on EDGAR

Where the sales came from

ALGN's results filing gives no sales by line in a table we read.

The outlook

The outlook the company gave, by period
MeasureFigure
Q4'26
Worldwide revenue$1.00B to $1.02B

Figures as filed (SEC filing, Oct 28)

14 more outlook lines, for Pro members.

The numbers

Market value
$11B
today
Sales
$4.1B
up 4.4% on the year
Free cash flow
$634M
last 12 months

Sales grew 10% a year over 5 years, fiscal 2020 to 2025.

Its share count fell 1.7% a year over 5 years.

4 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on ALGN: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.Get in free →
ReportedGapReaction5
sessions
Oct 28, 2026After close-0.4%+0.1%open
Jul 29, 2026After close+0.4%-3.7%-2.9%
Apr 29, 2026After close-0.8%-1.3%-2.5%

ALGN closed higher after 2 of its last 4 reports.

All 4 reports, and ALGN's Quality Score going into each

ALGN sales and profit by year

Sales and profit by year

Sales grew in six of the last seven years, to $4B in 2025. It made a profit in each of the eight years.

Insiders trading ALGN

ALGN trades by Congress and the executive branch

4 trades disclosed in the last six months. The newest:

SellRohit Khanna$1K to $15KHousetraded Sep 11, disclosed Oct 7(26 days later)
All 4 trades on ALGN disclosed by Congress and the executive branch, for Pro members.Get in free →

See what Congress is buying across the market

ALGN's officers and directors

Officers and directors with a Form 4 in the last 12 months.

6 more officers and directors file at ALGN. Each page above names the rest.

See insider trades by person

Which ETFs hold ALGN?

In ETFs: ALGN is under 0.1% of IVV, under 0.1% of SPY, and under 0.1% of VOO, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026 (SPY's as filed by IVV).

About Align Technology

Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.

20,435 employeesTempe, AZaligntech.com

What Align Technology says it competes with

“Our clear aligner products compete directly against traditional orthodontic treatments that use wires and brackets and increasingly against clear aligner products manufactured and distributed by various companies, both within and outside the United States.”

From its annual report, SEC filing · Feb 27, 2026

2 more sentences, what it says it does, and its sales by region, for Pro membersGet in free →

ALGN's score card

Align Technology (ALGN): Quality Score 4, Below Average, #45 of 85 in Medical Devices, with its price, on Breakaway
The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

  • What would turn ALGN's score around: 6 things
  • 3 more filings explained, a plain line each
  • Real-⁠time prices, no delay
BreakawayMay 11Rohit Khanna bought ALGN$1K to $15K, disclosed May 11

Alerts are optional.

See ALGN's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Nov 3, 2026: ALGN's Quality Score is 4 (Below Average), #45 of 85 in Medical Devices.

Is ALGN a good stock to buy? What its Quality Score says

ALGN scores 4 today, which Breakaway calls Below Average. It is #45 of 85 in Medical Devices by Quality Score, with 4 of 14 chart checks firing. Down 77% over five years while the S&P 500 rose 74%; up 11% in the past year. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is ALGN's Quality Score?

ALGN scores 4 today, which Breakaway calls Below Average (0 to 5). That is #45 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind ALGN's 4.

When does ALGN report earnings?

Expected to report Wed Feb 3, after the close, a date Breakaway expects from the company's usual timing; the company has not confirmed it. ALGN closed higher after 2 of its last 4 reports. Past behavior, not a forecast.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.

The moves after past earnings reports are past behavior, not a forecast.

The price, the score, the chart checks and readings, and the industry rank on this page are delayed at least 15 minutes.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs. Recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.